[Federal Register Volume 80, Number 39 (Friday, February 27, 2015)]
[Notices]
[Pages 10702-10703]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-04054]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications/contract proposals and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; IMAT Biospecimen Science Part 2.
    Date: March 17, 2015.
    Time: 11:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 2E030, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Donald L. Coppock, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W260, Bethesda, MD 20892, 240-276-6382, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Omnibus SEP-5.
    Date: March 26-27, 2015.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 10703]]

    Place: Gaithersburg Marriott Washingtonian Center, 9751 
Washingtonian Boulevard, Gaithersburg, MD 20878.
    Contact Person: Thomas A. Winters, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, 9609 Medical Center Drive, Room 7W412, 
Bethesda, MD 20892-9750, 240-276-6386, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Pediatric Preclinical Testing Consortium.
    Date: March 27, 2015.
    Time: 9:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W104, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Eun Ah Cho, Ph.D., Chief, Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W104, Bethesda, MD 20892-9750, 240-276-6342, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Cell-Free Nucleic Acid-Based Assays.
    Date: April 13-14, 2015.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Courtyard Gaithersburg Washingtonian Center, 204 
Boardwalk Place, Gaithersburg, MD 20878.
    Contact Person: Thomas M. Vollberg, Ph.D., Chief, Scientific 
Review Officer, Research Technology and Contract Review Branch, 
Division of Extramural Activities, National Cancer Institute, NIH, 
9609 Medical Center Drive, Room 7W102, Rockville, MD 20850, 240-276-
6341, [email protected].
    Information is also available on the Institute's/Center's home 
page: http://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: February 23, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-04054 Filed 2-26-15; 8:45 am]
BILLING CODE 4140-01-P